Can pricing end the obesity crisis? In this special edition of the Game Changer Newsletter, Arnab Sinha and I delve into an urgent global health crisis: obesity. We argue for a shift in pricing models—from per dose to per patient over time or per population—mirroring successful strategies in other industries. Our analysis suggests that such a transformation could significantly increase treatment reach, reduce health care costs, and provide a more attractive market for pharmaceutical companies. As we explore the potential of this innovative approach, the question becomes not if but how we can implement these changes to turn the tide on obesity. Join us in reimagining the future of health care pricing and access.
Can pricing end the obesity crisis
By
